Drug dose modifications and schedule and initiation of supportive care interventions are often necessary because of expected toxicities and. A randomized controlled trial of filgramstim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic lymphoma. Rtog 0617 calgb, ncctg phase iii trial of standarddose 60 gy versus highdose. Is the patient going to receive protocol treatment. Histologic documentation of prostatic adenocarcinoma. For data sent via sftp, a notification email should be sent to. Rtog lung cancer committee 2012 clinical trial update. Phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide jeffrey bogart, md state university of new york upstate medical university patients registered to calgb 30610 prior to the start of cycle 1 protocol treatment will. He previously served on the national cancer institute advanced technology consortium for clinical trials advisory committee and. Burkitt lymphoma part 1 of 3 the selection, dosing, and administration of anticancer agents and the management of associated toxicities are complex. A phase iii protocol of total androgen suppression tas and. A pediatric treatment approach to improve outcomes in adolescents and young adults with acute lymphoblastic leukemia katherine breitenbach, rn, msn, apn, and wendy stock, md of. Radiation therapy regimens in treating patients with. The nrg lung committee would like to share a study memo related to an update on a recent amendment for the alliance nctn trial calgb 30610rtog 0538.
Looks like it has been removed from the rtog website. Three different radiation therapy regimens in treating patients with limitedstage small cell lung cancer receiving cisplatin or carboplatin and. Radiation target volumes are defined by pretreatment petct scans. Calgb 80405 pdf asco, itt, kraswt primary os results. Phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide.
Prophylactic cranial irradiation overview collaborative group. Ongoing calgb 30610 trial is evaluating the control arm of 45 gy bid int0096 vs. C10403 protocol induction trial for all chemoexperts. Filter the listings by choosing the options in the drop down boxes and then click on the desired protocol number. Calgb 30610 phase iii comparison of thoracic radiotherapy regimens in patients with.
Acute lymphoblastic leukemia all part 1 of 11 note. Randomized phase iii study of neoadjuvant docetaxel and androgen deprivation prior to radical prostatectomy versus immediate radical prostatectomy in patients with highrisk, clinically localized prostate cancer fast facts eligibility criteria 1. A091401, randomized phase ii study of nivolumab with or without ipilimumab in patients with metastatic or unresectable sarcoma. Calgb 30610 thoracic radiotherapy for limited stage small cell. Calgb30610 phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin or carboplatin and etoposide a151216 adjuvant lung cancer enrichment marker. Protocol this trial protocol has been provided by the authors to give readers additional information about their work.
Radiation dose and fractionation for limitedstage smallcell lung. Sep 10, 2014 registration to calgb 30610 must take place within 1421 days after the start of the non protocol therapy. How do i treat a patient with limitedstage small cell. New calgb trials utilizing imaging protocol study chair imaging cochair calgb40502 hope rugo, m. Rtog lung cancer committee 2012 clinical trial update wally curran. Radiation therapy regimens in treating patients with limited. Additionally, these patients also must have met all of the eligibility criteria in the protocol prior to receiving the first cycle of chemotherapy. Failing to do all of the above will make the patient. Nrg clinical trials statistical reports january 2020. Capecitabine has the advantage of oral administration, and it targets tumor tissue. The following is a list of currently available studies.
Calgb 30610 phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide nct00632853. The c10403 regimen is an aggressive and complex treatment regimen for adolescents and young. New patients with limitedstage small cell lung cancer sclc are always tough to treat. Calgb 30610rtog 0538 piyunjie lin, md nct 00632853 coordinatorangie patterson a phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin or carboplatin and etoposide nrgcc003 piyunjie lin, md nct 02635009 coordinatorangie patterson. Proton chemoradiotherapy for inoperable stage iiiiib nsclc protocol version date 100515 iv. How do i treat a patient with limitedstage small cell lung. Name of institutional person registering this case yn 2. Since the trial was designed to show superiority of oncedaily radiotherapy and was not powered to show equivalence, the implication is that twice. Calgb failed to meet its primary endpoint of os cetuximab is not superior to avastin in 1l kraswt. This has led to a currently open phase iii trial to investigate bid vs high dose radiation, calgb30610. The protocol list provides a listing of nci clinical trials that are supported by the ctsu for which protocol documents are maintained on the ctsu members website. Mar 11, 2008 additionally, these patients also must have met all of the eligibility criteria in the protocol prior to receiving the first cycle of chemotherapy. Patients may have received one and only one cycle of chemotherapy prior to enrolling on calgb 30610, which must have included carboplatin or cisplatin and etoposide. This protocol serves as another arm of a current phase iii calgb trial.
Calgb 30610 thoracic radiotherapy for limited stage small cell lung cancer jeffrey a. Phase iii trial of trt regimens in patients with limitedstage small cell lung cancer receiving cisplatin and etoposide. The nccn recommends cancer patient participation in clinical trials as the gold standard for treatment. Mar 24, 2014 export to pdf export to word bioms public. Calgb 30610 rtog 0538 started as a 3 arm study designed to discontinue one of 2 experimental trt arms based on interim toxicity assessment, while the remaining arm would be compared against standard 4500 cgy twicedaily trt. This protocol was designed and developed by the radiation therapy oncology group rtog of the american college of radiology acr. Hematopoietic stem cell transplantation for adults with philadelphia chromosomenegative acute lymphoblastic leukemia in first remission. They demonstrated that the regimen of 45 gy bid in 3 weeks improved survival. Three different radiation therapy regimens in treating patients with limitedstage small cell lung cancer receiving cisplatin or carboplatin and etoposide. Calgb30610, phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin or carboplatin and etoposide protocol version date092717 v. Indiana university health ball memorial cancer center. Registration to calgb 30610 must take place within 1421 days after the start of the non protocol therapy. The feasibility of concurrent 70 gy qd was confirmed by calgb 39808. Acute leukemia group b, algb is a cancer research cooperative group in the united states calgb research is focused on seven major disease areas.
Its an aggressive cancer, with studies showing that our best therapy with concurrent cisplatinetoposide and thoracic radiation still yield a fiveyear survival rate of only about 20 to 26 percent. A phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide. For those who are not ctsu members this website provides a listing of active protocols that the ctsu supports along with links to resources for additional information on ncifunded clinical trials. Broadcasts rtog clinical trials protocol table study details. Since the trial was designed to show superiority of oncedaily radiotherapy and was not powered to show equivalence, the implication is that twicedaily radiotherapy should. Click the orange links and well show you extra information. Digital treatment plan, screenshots of other rt data and diagnostic imaging may be submitted via sftp or on cd. Normal tissue restraints are advised to follow the calgb 30610 rtog 0538 protocol. Concurrent oncedaily versus twicedaily chemoradiotherapy. Mar 28, 2020 calgb 80405 pdf asco, itt, kraswt primary os results. Failing to do all of the above will make the patient not eligible for calgb 30610. In a multivariate analysis adjusting for risk factors, treatment on the current calgb 2 chemoimmunotherapy regimen improved survival compared with the prior regimen of calgb 9251 hazard ratio 0. Calgb 30610rtog 0538 started as a 3 arm study designed to discontinue one of 2 experimental.
Paclitaxel with or without carboplatin andor bevacizumab. Since once daily radiation is widely adopted, calgb 30610rtog. Pulmonary toxicity in stage iii nonsmall cell lung cancer patients treated with highdose 74 gy 3dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy. Protocol list puerto rico ncorp rtog1216 randomized phase iiiii trial of surgery and postoperative radiation delivered with concurrent cisplatin versus docetaxel versus cetuximab and docetaxel for highrisk squamous cell cancer of the head and neck lung cancer calgb 140503 a phase iii randomized trial of lobectomy versus sublobar resection for. The trials on the list are either active, near activation, or temporarily closed. Three different radiation therapy regimens in treating. Lung committee would like to share a study memo related to an update on a recent amendment for the alliance nctn trial calgb 30610 rtog 0538. What is the optimal radiotherapy schedule for limited. The nccn guidelines for acute lymphoblastic leukemia all should be consulted for the management of patients with lymphoblastic lymphoma. Nrg oncology has pulled together a webpage to collate covid19 information for patients as well as for.
The nrg lung committee would like to share a study memo related to an update on a recent amendment for the alliance nctn trial calgb 30610 rtog 0538. Calgb data and safety monitoring board dsmb report is now available on the protocol documents list for the following calgb studies. C10403 induction is a chemotherapy regimen for acute lymphoid leukemia all weve made it easy for you to learn more. Calgb 30610, which must have included carboplatin or cisplatin and etoposide. Some studies of various fractionation schedules yielded promising results with a twicedaily regimen. Induction 4 wks cyclophosphamide cytoxan 1200 mgm2 800 mgm2 if pts older than 60 iv d1. Calgb 30610rtog 0538 started as a 3 arm study designed to discontinue one of 2 ex. Calgb 30610rtog 0538 started as a 3 arm study designed to discontinue one of 2 experimental trt arms based on interim toxicity assessment, while the remaining arm would be compared against standard 4500 cgy twicedaily trt. An intergroup phase ii clinical trial for adolescents and young adults with untreated acute lymphoblastic leukemia all.
Sep 10, 2014 issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Please read the memo on the ctsu website and help us enroll. My major interest for the last 15 years has been clinical pharmacology and drug development, and this is an interesting drug because its. However, the optimal radiation dosefractionation regimen is yet to be. Rtog 0538calgb 30610 protocol student doctor network.
Phase iii comparison of thoracic radiotherapy regimens in. Calgb 30610 rtog 0538 three different radiation therapy. Nrg oncology covid19 updates all of our sdmc and operations center staff have shifted to work remotely, and remain here to serve you. A randomized phase ii trial of myeloablative versus nonmyeloablative consolidation chemotherapy for newly diagnosed primary cns bcell lymphoma arm 1 and arm 2 receive the same induction therapy cycles 15.
The optimal trt regimen for lsclc remains to be defined. The protocol list contains information on nci clinical trials including accrual information. Daunorubicine 45 mgm2d 30 mgm2d if pts older than 60 iv d. Impact of induction chemotherapy on estimated risk of. Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Prophylactic cranial irradiation for patients with smallcell lung cancer in complete remission. Cyclophosphamide cytoxan 800 mgm2 iv d1 doxorubicin adriamycin 30 mgm2d iv d1, 2, 3 prednisone 60 mgm2. Calgb30610, phase iii comparison of thoracic radiotherapy regimens in patients. Trinity medical center cancer treatment protocols breast breast adjuvant protocol description bccr breast cancer collaborative registry ea11 a randomized phase iii postoperative trial of platinumbased chemotherapy vs. Radiation therapy regimens in treating patients with limitedstage small cell lung cancer receiving cisplatin and etoposide.
Management of all in adults national cancer institute. Image interpretation challenges and approaches to standardization lawrence schwartz, md department of radiology. The ctsu registration page contains detailed information and links for investigators and associates to obtain access to the ctsu members website. Interim toxicity analysis for patients with limited stage. Concurrent oncedaily versus twicedaily chemoradiotherapy in. High rate of grade 3 esophagitis indicates that tolerability of the treatment is. Cycle 1 4 wks cyclophosphamide cytoxan 1200 mgm2 iv d1 doxorubicin adriamycin 45 mgm2d iv d1, 2, 3 vincristine 2 mg iv d1, 8, 15, 22 prednisone 60 mgm2 po or iv qd d121 lasparaginase 6000 ium2 sc or im d5, 8, 11, 15, 18, 22 reduce doses if patients older than 60. Registration to calgb 30610 must take place within 1421 days after the start of the nonprotocol therapy. Protocol list the protocol list contains information on nci clinical trials including accrual information, and provides links to study abstracts and clinical sites that have the trial open. Survival outcomes did not differ between twicedaily and oncedaily concurrent chemoradiotherapy in patients with limitedstage smallcell lung cancer, and toxicity was similar and lower than expected with both regimens. A randomized phase ii trial of pet scandirected combined modality therapy for esophageal cancer. This is a randomized phase ii trial for patients with localized, surgically resectable esophageal cancer designed to evaluate the early assessment of response to chemotherapy by metabolic.
85 1018 1007 1266 918 915 995 983 444 1385 500 155 830 665 561 698 345 1056 1339 1131 1165 1218 278 795 1479 1442 448 758 424 20 1082 1200 1438 644 1508 524 841 1451 951 201 922 15 535 305 899 555 406 387